BRIEF published on 07/30/2024 at 00:05, 3 months 22 days ago KBC Group own share buyback program: update Investors Share Buyback Financial Transparency Euronext Brussels KBC Group
PRESS RELEASE published on 07/30/2024 at 00:00, 3 months 22 days ago Update regarding the KBC Group share buyback programme KBC Group provides an update on its share buyback program with detailed transaction information on Euronext Brussels' regulated market Share Buyback Regulated Market Euronext Brussels KBC Group Transaction Information
BRIEF published on 07/23/2024 at 00:05, 3 months 29 days ago Update on KBC Group's Share Buyback Programme Transactions Share Buyback Stock Market Euronext Brussels KBC Group
PRESS RELEASE published on 07/23/2024 at 00:00, 3 months 29 days ago Update regarding the KBC Group share buyback programme KBC Group provides update on share buyback program with transactions details on Euronext Brussels market Transactions Share Buyback Update Euronext Brussels KBC Group
BRIEF published on 07/16/2024 at 00:05, 4 months 5 days ago Update regarding the KBC Group share buyback program Share Buyback Buyback Program Euronext Brussels KBC Group
PRESS RELEASE published on 07/16/2024 at 00:00, 4 months 5 days ago Update regarding the KBC Group share buyback programme KBC Group provides update on share buyback program with details of transactions on Euronext Brussels between 8-12 July 2024. Total shares held and consideration disclosed Transactions Share Buyback Euronext Brussels Transparency Regulations KBC Group
BRIEF published on 07/09/2024 at 00:05, 4 months 12 days ago Update on the KBC Group share buyback program Transactions Share Buyback Own Shares Euronext Brussels KBC Group
PRESS RELEASE published on 07/09/2024 at 00:00, 4 months 12 days ago Update regarding the KBC Group share buyback programme KBC Group provides an update on the share buyback program, including transaction details and total shares held as of 5 July 2024 Share Buyback Program Regulated Market Euronext Brussels Transaction Details KBC Group
BRIEF published on 07/02/2024 at 00:05, 4 months 19 days ago Update on KBC Group Share Buyback Programme Share Buyback Financial Transactions Regulated Information Euronext Brussels KBC Group
PRESS RELEASE published on 07/02/2024 at 00:00, 4 months 19 days ago Update regarding the KBC Group share buyback programme KBC Group provides an update on the share buyback program, including transaction details on Euronext Brussels' market. Total own shares held and consideration disclosed Transactions Share Buyback Euronext Brussels Transparency Regulations KBC Group
Published on 11/21/2024 at 13:30, 30 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 30 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 1 hour ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 1 hour ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 1 hour ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 25 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 45 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 2 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 40 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 15 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 15 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
